Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03122301 · ClinicalTrials.gov registry record · Phase 2
Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer
A Phase 2 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT03122301: Clinical Trial Phase 2 study, sponsored by Northwestern University.
NCT03122301 is a Phase 2 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03122301, a Phase 2 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
Vasomotor symptoms (hot flashes, night sweats, VMS) affect up to 65% of breast cancer survivors and negatively impact their quality of life. VMS in Hispanic women are significantly more severe as compared to non-Hispanic Caucasian women. Few effective treatments for VMS are available, especially in the underserved Hispanic and Spanish-speaking populations which is problematic, as Hispanics will comprise 20% of the U.S. population by 2025. Stellate ganglion nerve block (SGB) with local anesthetic, previously performed for chronic pain indications, has shown promise as a potential treatment for menopausal women with VMS in previous clinical trials, but has not been investigated in Hispanic or Spanish-Speaking women with breast cancer in a controlled study.
Primary Outcome
2 month subject reported daily hot flashes measured from day 60 to day 90 after treatment (mean value).
Interventions
- DRUG Saline
- DRUG Stellate Ganglion Block injection with bupivicaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2020-07-01 |
| Phase | Phase 2 |
Why NCT03122301 stopped before completion
NCT03122301 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT03122301 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03122301 about?
NCT03122301 is a clinical study titled "Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer". Vasomotor symptoms (hot flashes, night sweats, VMS) affect up to 65% of breast cancer survivors and negatively impact their quality of life. VMS in Hispanic women are significantly more severe as compared to non-Hispanic Caucasian women. Few effective treatments for VMS are available, especially in ...
What is the current status of trial NCT03122301?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2017-06-01. Estimated completion is 2020-07-01.
What interventions are being tested in trial NCT03122301?
The interventions under investigation include: Saline (DRUG), Stellate Ganglion Block injection with bupivicaine (DRUG).
Who is sponsoring clinical trial NCT03122301?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03122301's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI